Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
Rubella
SAGE documentation
Evidence to recommendation table
Clear all
Type of publications
SAGE documentation
(6)
Topics
Evidence to recommendation table
(6)
Regions
Countries
Diseases
COVID-19
(2)
Pneumococcal disease
(2)
Rubella
(2)
Dengue
(2)
Diphtheria
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(3)
Influenza
(1)
Malaria
(2)
Measles
(2)
Mpox // Monkeypox
(1)
Pertussis
(1)
Rabies
(2)
Typhoid
(1)
Publication date
2022
(1)
2021
(1)
2020
(1)
2017
(2)
Target population
Available to download in languages
English (EN)
(6)
6 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2020
∙
SAGE
Which combined rubella and congenital rubella syndrome (CRS) control and elimination strategies should be recommended?
2017
∙
SAGE
Grade Tables - PCV
2017
∙
SAGE
SAGE evidence to recommendations table: Pneumococcal Conjugate Vaccine (PCV)
SAGE
Does the evidence support co-administration of measles-rubella (MR)/measles-mumps-rubella (MMR) and yellow fever (YF) vaccines?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register